Verano Holdings (VRNO) Change in Cash (2021 - 2026)
Verano Holdings' (VRNO) quarterly Change in Cash came in at -$8.7 million in Q1 2026, down 143.23% year-on-year from $20.1 million in Q1 2025, and down 8463.46% on a QoQ basis from $104000.0 in Q4 2025.
Verano Holdings (VRNO) Change in Cash (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Change in Cash data on file, last reported at -$8.7 million in Q1 2026.
- On a quarterly basis, Change in Cash fell 143.23% year-over-year to -$8.7 million in Q1 2026; TTM through Mar 2026 was -$10.2 million, a 90.7% increase from a year earlier, with the FY2025 full-year figure at -$5.1 million, up 94.17% from the prior year.
- Change in Cash for Q1 2026 stood at -$8.7 million, down from $104000.0 in the prior quarter.
- Over the last five years, Change in Cash for VRNO reached as high as $44.8 million in Q4 2023 and fell as low as -$65.1 million in Q3 2024.
- Historically, Change in Cash has averaged -$1.5 million across 5 years, with a median of $7.4 million in 2023.
- Across the five-year window, Change in Cash soared 424.81% in 2023 and tumbled 955.78% in 2024, its largest moves.
- Year by year, Change in Cash stood at $8.5 million in 2022, then surged by 424.81% to $44.8 million in 2023, then slumped by 49.13% to $22.8 million in 2024, then plunged by 99.54% to $104000.0 in 2025, then slumped by 8463.46% to -$8.7 million in 2026.
- Per Business Quant data, the three most recent Change in Cash figures were -$8.7 million in Q1 2026, $104000.0 in Q4 2025, and $14.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 185.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -509.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -388.85 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 457.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -117.00 Mn |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn | -8.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.70 Mn |
| Dec 31, 2025 | 104,000.00 |
| Sep 30, 2025 | 14.05 Mn |
| Jun 30, 2025 | -15.65 Mn |
| Mar 31, 2025 | -3.58 Mn |
| Dec 31, 2024 | 22.81 Mn |
| Sep 30, 2024 | -65.07 Mn |
| Jun 30, 2024 | -63.75 Mn |
| Mar 31, 2024 | 19.02 Mn |
| Dec 31, 2023 | 44.84 Mn |
| Sep 30, 2023 | 27.35 Mn |
| Jun 30, 2023 | 7.45 Mn |
| Mar 31, 2023 | 10.28 Mn |
| Dec 31, 2022 | 8.54 Mn |
| Sep 30, 2022 | -16.52 Mn |
| Jun 30, 2022 | -46.80 Mn |
| Mar 31, 2022 | 40.52 Mn |
| Dec 31, 2021 | 42.18 Mn |
| Sep 30, 2021 | -92.73 Mn |